|
| 34670844 | Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations. | Journal of Neurology, Neurosurgery and Psychiatry | 2023 |
| 36423459 | Cancer related mortality in multiple sclerosis. A population based cohort study. | Multiple Sclerosis and Related Disorders | 2023 |
| 37816262 | Ocrelizumab and ofatumumab, but not rituximab, trigger complement induction in vitro. | | 2023 |
| 37804765 | Humoral response to Epstein-Barr virus in patients with multiple sclerosis treated with B cell depletion therapy. | | 2023 |
| 37479464 | Childbirth delivery mode and the risk of multiple sclerosis: a prospective population-based study. | | 2023 |
| 36718905 | New centres to carry out more clinical trials in Norway. | | 2023 |
| 36701908 | Interferon β1a treatment does not influence serum Epstein-Barr virus antibodies in patients with multiple sclerosis. | | 2023 |
| 36462469 | Brief international cognitive assessment for MS (BICAMS) and global brain volumes in early stages of MS - A longitudinal correlation study. | Multiple Sclerosis and Related Disorders | 2023 |
| 37349545 | Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis. | | 2023 |
| 35173016 | Relationship Between White Matter Lesions and Gray Matter Atrophy in Multiple Sclerosis: A Systematic Review. | Neurology | 2022 |
| 35910410 | Ocrelizumab quantitation by liquid chromatography-tandem mass spectrometry. | Journal of Mass Spectrometry and Advances in the Clinical Lab | 2022 |
| 35462167 | Risk of fingolimod rebound after switching to cladribine or rituximab in multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2022 |
| 35649699 | Serum neurofilament as a predictor of 10-year grey matter atrophy and clinical disability in multiple sclerosis: a longitudinal study. | Journal of Neurology, Neurosurgery and Psychiatry | 2022 |
| 36096665 | Mortality and cause of death in multiple sclerosis in western Norway 1950-2021: a registry-based linkage study. | Journal of Neurology, Neurosurgery and Psychiatry | 2022 |
| 36286559 | Breastfeeding and treatment for multiple sclerosis. | Tidsskrift for den Norske Laegeforening | 2022 |
| 35379699 | Association of adverse childhood experiences with the development of multiple sclerosis. | Journal of Neurology, Neurosurgery and Psychiatry | 2022 |
| 35879056 | Safety of breast feeding during rituximab treatment in multiple sclerosis. | Journal of Neurology, Neurosurgery and Psychiatry | 2022 |
| 35738901 | The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. | Neurology: Neuroimmunology and NeuroInflammation | 2022 |
| 35780399 | Abuse and revictimization in adulthood in multiple sclerosis: a cross-sectional study during pregnancy. | Journal of Neurology | 2022 |
| 35278068 | Strong tuberculin response after BCG vaccination is associated with low multiple sclerosis risk: a population-based cohort study. | International Journal of Epidemiology | 2022 |
| 34978580 | The effect of gadolinium-based contrast-agents on automated brain atrophy measurements by FreeSurfer in patients with multiple sclerosis. | European Radiology | 2022 |
| 34474301 | Wearing-off symptoms during standard and extended natalizumab dosing intervals: Experiences from the COVID-19 pandemic. | Journal of the Neurological Sciences | 2021 |
| 33636616 | Low vitamin D, but not tobacco use or high BMI, is associated with long-term disability progression in multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2021 |
| 33796328 | Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis - A cohort study. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2021 |
| 33785790 | Cuprizone and EAE mouse frontal cortex proteomics revealed proteins altered in multiple sclerosis. | Scientific Reports | 2021 |
| 33623706 | Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2021 |
| 34047171 | Disease-modifying therapy for multiple sclerosis. | Tidsskrift for den Norske Laegeforening | 2021 |
| 33883236 | Perinatal Depression and Anxiety in Women With Multiple Sclerosis: A Population-Based Cohort Study. | Neurology | 2021 |
| 33602999 | Cerebrospinal fluid proteome shows disrupted neuronal development in multiple sclerosis. | Scientific Reports | 2021 |
| 34188949 | Real-world discontinuation rate of teriflunomide and dimethyl fumarate in multiple sclerosis. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2021 |
| 33360174 | Comorbidity in multiple sclerosis patients from Nordland County, Norway - validated data from the Norwegian Patient Registry. | Multiple Sclerosis and Related Disorders | 2021 |
| 33011853 | Recent progress in maintenance treatment of neuromyelitis optica spectrum disorder. | Journal of Neurology | 2021 |
| 34900328 | CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2021 |
| 34419754 | Incidence of cancer in multiple sclerosis before and after the treatment era- a registry- based cohort study. | Multiple Sclerosis and Related Disorders | 2021 |
| 33049462 | Tenofovir as a treatment option for multiple sclerosis. | Multiple Sclerosis and Related Disorders | 2020 |
| 32425877 | Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis. | Frontiers in Neurology | 2020 |
| 32019768 | Wearing-off at the end of natalizumab dosing intervals is associated with low receptor occupancy. | Neurology: Neuroimmunology and NeuroInflammation | 2020 |
| 31739156 | Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model. | Journal of Neuroimmunology | 2020 |
| 32413799 | Wearing-off at the end of natalizumab dosing interval and risk of MS disease activity: A prospective 1-year follow-up study. | Journal of the Neurological Sciences | 2020 |
| 32064116 | Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. | Multiple Sclerosis Journal - Experimental, Translational and Clinical | 2020 |
| 31833798 | Safety and efficacy of autologous hematopoietic stem cell transplantation for multiple sclerosis in Norway. | Multiple Sclerosis Journal | 2020 |
| 31625829 | Serum NFL levels should be used to monitor multiple sclerosis evolution - No. | Multiple Sclerosis Journal | 2020 |
| 31573834 | Risk of cancer among multiple sclerosis patients, siblings, and population controls: A prospective cohort study. | Multiple Sclerosis Journal | 2020 |
| 32217642 | High incidence and prevalence of MS in Møre and Romsdal County, Norway, 1950-2018. | Neurology: Neuroimmunology and NeuroInflammation | 2020 |
| 33101459 | Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden. | Therapeutic Advances in Neurological Disorders | 2020 |
| 33296975 | A two-year longitudinal follow-up of cognitive performance assessed by BICAMS in newly diagnosed patients with MS. | Multiple Sclerosis and Related Disorders | 2020 |
| 30688025 | Optimization of Receptor Occupancy Assays in Mass Cytometry: Standardization Across Channels with QSC Beads. | Cytometry. Part A : the journal of the International Society for Analytical Cytology | 2019 |
| 31583850 | Validation of the multiple sclerosis diagnosis in the Norwegian Patient Registry. | Brain and Behavior | 2019 |
| 31887199 | The association between exposure to interferon-beta during pregnancy and birth measurements in offspring of women with multiple sclerosis. | PLoS ONE | 2019 |
| 31610403 | The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). | Multiple Sclerosis and Related Disorders | 2019 |